Prothena
PRTA
$66.39
Share price
-0.06%
Change (1 day)
150.34%
Change (1 year)
Categories
Market capitalization of Prothena (PRTA)
Market cap: $3.50 Billion
As of June 2023 Prothena has a market cap of $3.50 Billion. This makes Prothena the world's 2961th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Prothena from 2012 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $3.50 B | 12.59% |
| 2022 | $3.11 B | 35.14% |
| 2021 | $2.30 B | 380.07% |
| 2020 | $0.47 B | -24.09% |
| 2019 | $0.63 B | 53.82% |
| 2018 | $0.41 B | -71.51% |
| 2017 | $1.44 B | -15.04% |
| 2016 | $1.69 B | -21.53% |
| 2015 | $2.16 B | 280.26% |
| 2014 | $0.56 B | -1.91% |
| 2013 | $0.57 B | 347.29% |
| 2012 | $0.12 B |
End of Day market cap according to different sources
On Jun 1st, 2023 the market cap of Prothena was reported to be:
$3.50 Billion
$3.50 Billion
$3.50 Billion
$3.50 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Amarin Corporation
AMRN | $0.49 B | -85.91% | 🇮🇪 Ireland |
 Alnylam Pharmaceuticals
ALNY | $23.49 B | 570.85% | 🇺🇸 USA |
 Alkermes ALKS | $4.86 B | 38.89% | 🇮🇪 Ireland |